A safety and efficacy study of AAV2-haadc for aadc deficiency

Active Grant Awarded Last action

Award ID
R01NS094292
Recipient
Awarding agency
Obligated
$17,332,929

Award facts

Completion date 93% complete
Originally
Place of performance
Columbus, OH 43210, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $2,249,678
Amendment $2,242,039
Amendment $2,665,330
Amendment $0
Amendment $0
Amendment A safety and efficacy study of AAV2-haadc for AADC deficiency - the goal of this proposal is to further evaluate the safety and feasibility of gene transfer… -$0
Amendment $3,470,061
Amendment -$58,518
Amendment A safety and efficacy study of AAV2-HAADC for aadc deficiency - description (provided by applicant): aadc deficiency is a genetic disorder. IT is caused by… $58,518
Amendment A safety and efficacy study of AAV2-haadc for AADC deficiency - the goal of this proposal is to further evaluate the safety and feasibility of gene transfer… $3,683,088
Amendment $412,592
Amendment $0
Amendment $0
Amendment $138,563
Amendment $493,460
Amendment $126,850
Amendment $883,538
Original award $967,730
Show all 18

Subawards

Subrecipient Amount Awarded
Research Institute At Nationwide Children's Hospital Nationwide Children's Hospital is serving as a site for the multi-center clinical trial entitled, "A Single-Stage, Adaptive, Open-Label, Dose Escalation… $406,321
The Regents Of The University Of California. San Francisco A safety and efficacy study of AAV2-hAADC for AADC deficiency $648,443
Research Institute At Nationwide Children's Hospital Nationwide Children's Hospital is serving as a site for the multi-center clinical trial entitled, "A Single-Stage, Adaptive, Open-Label, Dose Escalation… $456,321
The Feinstein Institutes For Medical Research For the proposed project, Dr. Eidelberg's team at the Feinstein Institutes for Medical Research (FIMR) will analyze [18F]-fluoro-L-DOPA (FDOPA) and… $73,608
Hugo W. Moser Research Institute At Kennedy Krieger, Inc. Dr. Erika Augustine, as the designated medical monitor, will work with the study team in the oversight of safety of all trial participants. Dr. Augustine will… $19,095
The Regents Of The University Of California. San Francisco A safety and efficacy study of AAV2-hAADC for AADC deficiency $648,443
Research Institute At Nationwide Children's Hospital Nationwide Children’s Hospital is serving as a site for the multi-center clinical trial entitled, “A Single-Stage, Adaptative, Open-Label, Dose Escalation… $391,314
Kennedy Krieger Institute, Inc. A safety and efficacy study of AAV2-hAADC for AADC deficiency $19,095
The Feinstein Institutes For Medical Research For the proposed project, Dr. Eidelberg's team at the Feinstein Institutes for Medical Research (FIMR) will analyze [18F]-fluoro-L-DOPA (FDOPA) and… $53,863
The Regents Of The University Of California. San Francisco A safety and efficacy study of AAV2-hAADC for AADC deficiency $417,964

Quick answers

Who received award R01NS094292?

R01NS094292 was awarded to The Ohio State University by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on July 20, 2016.

How much is award R01NS094292 worth?

$17,332,929 has been obligated on R01NS094292.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award